Search
Feed aggregator
Coherus, Junshi’s PD-1 Blocker Loqtorzi Aces Phase III Liver Cancer Trial
Coherus, Junshi’s PD-1 Blocker Loqtorzi Aces Phase III Liver Cancer Trial 6/13/2024
Career Coach: How to Navigate 2 Job Interviews at the Same Company
Career Coach: How to Navigate 2 Job Interviews at the Same Company 6/13/2024
Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases
Moderna’s mRNA Candidate Joins FDA’s Accelerator Program for Rare Diseases 6/6/2024
Novo’s Ozempic, Wegovy to Face Stiff Generic Competition in China: Reuters
Novo’s Ozempic, Wegovy to Face Stiff Generic Competition in China: Reuters 6/6/2024
Amgen Phase III Win Positions Uplizna for Label Expansion in Rare Autoimmune Disease
Amgen Phase III Win Positions Uplizna for Label Expansion in Rare Autoimmune Disease 6/6/2024
BioSpace x DIA: Robust Integrated Regulatory Strategies
BioSpace x DIA: Robust Integrated Regulatory Strategies 6/6/2024
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report
Life Sciences R&D, Manufacturing Talent Becoming More Difficult to Find: Report 6/6/2024
Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees
Embracing Inclusivity: How Biopharmas Connect With LGBTQ+ Employees 6/6/2024
Telix Targets $200M IPO in Hot Radiopharma Market as Biotech Nasdaq Offerings Slow
Telix Targets $200M IPO in Hot Radiopharma Market as Biotech Nasdaq Offerings Slow 6/6/2024
You’re More Than Your Job: Finding Self-Worth Outside of Work
You’re More Than Your Job: Finding Self-Worth Outside of Work 6/6/2024
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector
ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector 5/6/2024
Opinion: Can Ketamine Be Safely Used at Home?
Opinion: Can Ketamine Be Safely Used at Home? 5/6/2024
5 DMD Data Readouts to Watch in 2024
5 DMD Data Readouts to Watch in 2024 5/6/2024
AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases
AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases 5/6/2024
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment
FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment 4/6/2024
ASCO24: Novartis Leukemia Drug Beats Older Drugs in Phase III Readout
ASCO24: Novartis Leukemia Drug Beats Older Drugs in Phase III Readout 5/31/2024
Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial
Gilead’s Trodelvy Fails to Reach Primary Endpoint in Confirmatory Trial 5/31/2024
FDA Delays Dupixent Uncontrolled COPD Decision as EU Panel Recommends Approval
FDA Delays Dupixent Uncontrolled COPD Decision as EU Panel Recommends Approval 5/31/2024
ASCO24 Preview: A Look at Some of the Cancer Meeting’s Hottest Abstracts
ASCO24 Preview: A Look at Some of the Cancer Meeting’s Hottest Abstracts 5/31/2024
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024
Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024 5/31/2024
World Pharma News
- How the cheese-noodle principle could help counter Alzheimer's
- New 'sensor' lets researchers watch DNA repair in real time
- The immune system creates its own targets within viruses
- Targeted drug could benefit young patients with invasive sarcoma
- Next-generation microbiome medicine may revolutionize the treatment of Parkinson's and similar disorders